related announcements

News

Ventyx Biosciences Inc.

Ventyx Biosciences Announces Results from the Phase 2 Trial of VTX958[...]
Quanterix Corporation

Quanterix Presents Data Demonstrating Successful Multi Marker Approach[...]
U.S. Department of State

Joint Statement from the Quad Foreign Ministers’ Meeting in Tokyo

Healthcare

Pyxis Oncology Inc.

Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference
Insmed Inc.

Insmed to Host Second-Quarter 2024 Financial Results Conference Call on[...]
Bunker Hill Mining Corporation

Bunker Hill Announces an Enhanced Digbee ESG Rating

Eledon Pharmaceuticals Inc.

07/29/2024 | Press release | Distributed by Public on 07/29/2024 05:39

Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Sharing and Personal Tools

Please select the service you want to use: